{
    "clinical_study": {
        "@rank": "95803", 
        "arm_group": [
            {
                "arm_group_label": "Amoxicillin", 
                "arm_group_type": "Active Comparator", 
                "description": "Amoxicillin 500mg three times in a day for 1 week"
            }, 
            {
                "arm_group_label": "Erythromycin", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Erythromycin 500mg four times in a day for 1 week"
            }
        ], 
        "brief_summary": {
            "textblock": "PREGNANT WOMEN IN ANTENATAL CLINIC WILL BE SCREENED FOR CHLAMYDIA TRACHOMATIS INFECTION WITH\n      ENDOCERVICAL SWAB.THOSE THAT TEST POSITIVE AND SATISFY THE INCLUSION CRITERIA WILL BE\n      COUNSELLED AND ENROLLED INTO THE STUDY AFTER OBTAINING INFORMED CONSENT.THE PARTICIPANTS\n      WILL BE RANDOMISED INTO ONE OF THE TWO GROUPS.THE DRUGS WILL BE TAKEN FOR I WEEK AND THE\n      SEXUAL PARTNER(S) WILL ALSO BE TREATED WITH DOXYCYCLINE FOR 1 WEEK. BARRIER CONTRACEPTION\n      WILL ALSO BE USED DURING THE TREATMENT.THE SEXUAL PARTNERS WILL BE CONTACTED THROUGH\n      TELEPHONE CALLS AND THE BENEFITS OF PARTICIPATING IN THE STUDY WILL BE EXPLAINED TO THEM.\n      LATEX MALE CONDOM WILL BE GIVEN TO THE WOMEN. ALSO, FOLLOW-UP TELEPHONE CALLS WILL BE PUT\n      ACROSS TO THEM DURING THE TREATMENT WEEK TO ENHANCE COMPLIANCE. A REPEAT ENDOCERVICAL SWAB\n      WILL BE TAKEN 4 WEEKS AFTER TREATMENT TO CHECK FOR MICROBIOLOGICAL CLEARANCE. A STUDY\n      PROFORMA WILL BE FILLED DURING THIS VISIT. THE DATA WILL BE ANALYSED USING STATISTICAL\n      PACKAGE FOR SOCIAL SCIENCES VERSION 17."
        }, 
        "brief_title": "Treatment of Antenatal Chlamydia Infection", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "condition": "Chlamydia Trachomatis Infection in Pregnancy", 
        "condition_browse": {
            "mesh_term": "Chlamydia Infections"
        }, 
        "detailed_description": {
            "textblock": "AIM(S) OF THE RESEARCH TO ASSESS THE EFFICACY AND TOLERABILITY OF AMOXICILLIN COMPARED TO\n      ERYTHROMYCIN IN TREATMENT OF ANTENATAL CHLAMYDIA INFECTION\n\n      OBJECTIVES OF THE RESEARCH\n\n        -  TO DETERMINE THE PREVALENCE OF CHLAMYDIA TRACHOMATIS INFECTION IN   PREGNANCY\n\n        -  TO COMPARE THE PROPORTION OF SUBJECTS WITH CLEARANCE OF ANTENATAL CHLAMYDIA TRACHOMATIS\n           INFECTION BETWEEN THE ERYTHROMYCIN AND AMOXICILLIN GROUPS\n\n        -  TO COMPARE THE OCCURENCE OF SIDE EFFECTS BETWEEN THE TWO GROUPS\n\n        -  TO COMPARE THE DRUG DISCONTINUATION RATES BETWEEN THE TWO GROUP"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Test positive to Chlamydia rapid screening kit\n\n          2. Estimated gestational age less than 36 weeks\n\n          3. Consent to participate in the study\n\n          4. Willingness or ability to comply with follow-up schedule\n\n        Exclusion Criteria:\n\n          1. Antenatal patients whose gestational age is more than 36 weeks\n\n          2. History of reaction to any of the drugs\n\n          3. Women with low lying placenta or placenta Praevia\n\n          4. History of other antibiotics intake within two weeks of recruitment"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 16, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01946256", 
            "org_study_id": "ERC/2013/09/06"
        }, 
        "intervention": [
            {
                "arm_group_label": "Amoxicillin", 
                "intervention_name": "Amoxicillin", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Erythromycin", 
                "intervention_name": "Erythromycin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Amoxicillin", 
                "Erythromycin", 
                "Erythromycin Estolate", 
                "Erythromycin Ethylsuccinate", 
                "Erythromycin stearate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 26, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Ile Ife", 
                    "country": "Nigeria", 
                    "state": "Imesi Ile", 
                    "zip": "220001"
                }, 
                "name": "Obafemi Awolowo University Teaching Hospitals Complex, Ile Ife"
            }
        }, 
        "location_countries": {
            "country": "Nigeria"
        }, 
        "number_of_arms": "2", 
        "official_title": "Erythromycin Versus Amoxicillin for Treatment of Antenatal Chlamydia Trachomatis Infection: A Randomized Controlled Trial", 
        "other_outcome": {
            "description": "Occurrence of side effects will be considered between the two groups. The side effects include nausea, diarrhoea,vomiting and loss of appetite", 
            "measure": "occurrence of side effect.", 
            "safety_issue": "Yes", 
            "time_frame": "1 week"
        }, 
        "overall_official": {
            "affiliation": "Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife", 
            "last_name": "Temitope O Okunola, MB;BS", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Nigeria: Federal Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "March 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "The women will be screened 4 weeks after treatment to check for microbiological clearance", 
            "measure": "completion of course of medication and microbiological clearance", 
            "safety_issue": "No", 
            "time_frame": "4 weeks after treatment"
        }, 
        "reference": {
            "PMID": "7968119", 
            "citation": "Alary M, Joly JR, Moutquin JM, Mondor M, Boucher M, Fortier A, Pinault JJ, Paris G, Carrier S, Chamberland H, et al. Randomised comparison of amoxycillin and erythromycin in treatment of genital chlamydial infection in pregnancy. Lancet. 1994 Nov 26;344(8935):1461-5."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01946256"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Obafemi Awolowo University Teaching Hospital", 
            "investigator_full_name": "Okunola Temitope Omoladun", 
            "investigator_title": "Erythromycin versus Amoxicillin for treatment of antenatal Chlamydia infection: a randomized controlled trial", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "The drug discontinuation rates between the two groups will be compared", 
            "measure": "drug discontinuation rates", 
            "safety_issue": "No", 
            "time_frame": "within 1 week of treatment"
        }, 
        "source": "Obafemi Awolowo University Teaching Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Obafemi Awolowo University Teaching Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}